UHS(US:UHS) Prnewswire·2025-10-27 20:16Core Insights - Universal Health Services, Inc. (UHS) reported a significant increase in net income and revenues for the third quarter of 2025 compared to the same period in 2024, with net income attributable to UHS rising to $373.0 million, or $5.86 per diluted share, from $258.7 million, or $3.80 per diluted share, and net revenues increasing by 13.4% to $4.495 billion from $3.963 billion [1][4][27] Financial Performance - Adjusted net income for the third quarter of 2025 was $362.3 million, or $5.69 per diluted share, compared to $252.5 million, or $3.71 per diluted share, in the third quarter of 2024 [2][29] - For the first nine months of 2025, reported net income attributable to UHS was $1.043 billion, or $16.07 per diluted share, up from $809.7 million, or $11.88 per diluted share, in the same period of 2024 [4][27] - Net revenues for the first nine months of 2025 increased by 9.9% to $12.879 billion from $11.714 billion in 2024 [4][29] Operational Metrics - In the third quarter of 2025, adjusted admissions at acute care hospitals increased by 2.0%, and adjusted patient days rose by 0.4% compared to the third quarter of 2024 [6] - Net revenue per adjusted admission increased by 9.8%, and net revenue per adjusted patient day increased by 11.5% during the same period [6] - For the first nine months of 2025, adjusted admissions at acute care hospitals increased by 2.1%, while adjusted patient days increased by 0.6% compared to the same period in 2024 [8] Cash Flow and Liquidity - Net cash provided by operating activities for the first nine months of 2025 was $1.290 billion, down from $1.409 billion in the same period of 2024 [11] - As of September 30, 2025, UHS had $965 million of available borrowing capacity under its revolving credit facility [12] Stock Repurchase Program - The Board of Directors authorized a $1.5 billion increase to the stock repurchase program, bringing the total available repurchase authorization to $1.759 billion [12] - In the third quarter of 2025, UHS repurchased 1.315 million shares at an aggregate cost of approximately $234.3 million [12] Revised Operating Results Forecast - UHS revised its 2025 operating results forecast, increasing the range for consolidated net revenues and adjusted EBITDA, net of noncontrolling interests [13][22] - The revised forecast for net revenues is between $17.306 billion and $17.445 billion, with adjusted EBITDA projected at $2.569 billion [15][22]